Skip to main content

DNB Asset Management AS

Source: SEC Form 13F · as of Mar 2026

DNB Asset Management AS holds 53 biotech & pharma companies tracked by BioSniper, totaling $219.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

53

Total value held

$219.2M

BioSniper AIPage evidence connected

Prepared research question

What matters most for BIOMARIN PHARMACEUTICAL INC (BMRN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
BMRNBIOMARIN PHARMACEUTICAL INC1,221,387$69.0M
GILDGILEAD SCIENCES, INC.273,107$38.1M
REGNREGENERON PHARMACEUTICALS, INC.43,381$33.5M
AXSMAxsome Therapeutics, Inc.90,088$15.2M
ALNYALNYLAM PHARMACEUTICALS, INC.31,427$10.4M
INSMINSMED Inc53,170$8.7M
TEVATeva Pharmaceutical Industries Limited233,895$7.0M
IRONDisc Medicine, Inc.96,755$6.2M
RVMDREVOLUTION MEDICINES, INC.36,187$3.5M
INCYIncyte Corp.34,157$3.2M
MRNAModerna, Inc.51,901$2.6M
ROIVRoivant Sciences Ltd.73,020$2.0M
IONSIONIS PHARMACEUTICALS INC19,060$1.4M
BBIOBridgeBio Pharma, Inc.16,841$1.3M
PCVXVaxcyte, Inc.19,100$1.1M
SRRKScholar Rock Holding Corp21,958$1.1M
RYTMRHYTHM PHARMACEUTICALS, INC.11,195$974K
SMMTSummit Therapeutics Inc.50,558$959K
CYTKCYTOKINETICS INC12,898$850K
VKTXViking Therapeutics, Inc.24,071$783K
TGTXTG THERAPEUTICS, INC.20,815$691K
NAMSNEWAMSTERDAM PHARMA CO N.V.21,558$690K
APGEApogee Therapeutics, Inc.7,991$673K
ARQTArcutis Biotherapeutics, Inc.25,401$598K
CLDXCelldex Therapeutics, Inc.18,087$574K
EXELEXELIXIS, INC.12,903$553K
JAZZJazz Pharmaceuticals plc2,927$553K
NUVLNuvalent, Inc.5,199$533K
ANNXAnnexon, Inc.88,617$491K
OCULOCULAR THERAPEUTIX, INC53,109$450K
SLNOSOLENO THERAPEUTICS INC13,366$447K
CNTACentessa Pharmaceuticals plc10,394$413K
ACADACADIA PHARMACEUTICALS INC18,523$412K
ARWRARROWHEAD PHARMACEUTICALS, INC.6,487$407K
GPCRStructure Therapeutics Inc.8,188$395K
QUREuniQure N.V.21,120$345K
VRDNViridian Therapeutics, Inc.\DE15,984$313K
PTCTPTC THERAPEUTICS, INC.4,369$298K
APLSApellis Pharmaceuticals, Inc.6,184$249K
PTGXProtagonist Therapeutics, Inc2,244$237K
LGNDLigand Pharmaceuticals Incorporated1,107$221K
FOLDAMICUS THERAPEUTICS, INC.14,662$212K
UPBUpstream Bio, Inc.23,515$212K
DNLIDenali Therapeutics Inc.10,959$210K
LENZLENZ Therapeutics, Inc.20,780$190K
RGNXREGENXBIO Inc.20,326$170K
IBRXImmunityBio, Inc.18,843$145K
ADMAADMA BIOLOGICS, INC.15,268$138K
OGNOrganon & Co.18,926$113K
RXRXRECURSION PHARMACEUTICALS, INC.30,607$94K
GERNGERON CORP52,376$78K
ABUSArbutus Biopharma Corp14,643$66K
ATAIAtai Beckley N.V.13,572$48K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.